Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-18-003074)

Filing Details

Accession Number:: 0001562180-18-003074
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-21 16:20:17
Reporting Period:: 2018-06-19

Accepted Time:: 2018-06-21 16:20:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100412	Array Biopharma Inc	ARRY	Pharmaceutical Preparations (2834)	841460811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1620368	Victor Sandor	C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-19	77,576	$3.65	287,662	No	4	M	Direct
Common Stock	Disposition	2018-06-19	77,576	$18.76	210,086	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-06-19	77,576	$0.00	77,576	$3.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
279,259		2024-09-22	No	4	M	Direct

Footnotes

These trades were made pursuant to a Rule 10b5-1 trading plan.
The price reported for these shares is the weighted average sale price of transactions made at prices from $18.75 to $18.845. Details of actual prices for shares sold are available from the Issuer upon request.
The option vested in four equal annual installments beginning on September 22, 2015.